Literature DB >> 19540434

Expression of prosalusin in human neuroblastoma cells.

Chisato Nakayama1, Masayoshi Shichiri, Kengo Sato, Yukio Hirata.   

Abstract

Salusins, which are derived from the prosalusin precursor molecule, regulate hemodynamics, mitogenesis and atherogenesis. The preprosalusin gene is ubiquitously expressed, while the salusin-beta peptide is present in systemic endocrine cells and the neuroendocrine system. However, the regulatory mechanisms for the preprosalusin gene and prosalusin expression remain to be investigated. Real-time quantitative RT-PCR and salusin-alpha radioimmunoassay revealed that the neuroblastoma cell line, SK-N-SH, exhibited marked upregulation of preprosalusin mRNA and salusin-alpha-like immunoreactivity (LI) when incubated under 2% serum condition. However, SK-N-SH cells released a limited amount of salusin-alpha-LI into the culture supernatant. Reverse-phase high performance liquid chromatography coupled with radioimmunoassay after extraction of proteins from the conditioned media using an octyl-silica column did not reveal a component that co-eluted with authentic salusin-alpha. Western blotting of the nuclear extracts from SK-N-SH showed the expression of prosalusin and its cleaved fragments, but not authentic salusin-alpha. Addition of Jak-2 inhibitors to growing SK-N-SH cells cultured under 10% serum condition resulted in increased salusin-alpha-LI expression. Suppression of Jak-2 mRNA using siRNAs upregulated intracellular salusin-alpha-LI, as detected by immunofluorescence. In summary, the preprosalusin gene and prosalusin protein are expressed in a neuroblastoma cell line and upregulated by reduced serum. The Jak-2 pathway may be involved in the regulation of salusin expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540434     DOI: 10.1016/j.peptides.2009.03.021

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  6 in total

1.  Relationship of salusin-alpha and salusin-beta levels with atherosclerosis in patients undergoing haemodialysis.

Authors:  Savas Sipahi; Ahmed Bilal Genc; Seyyid Bilal Acikgoz; Mehmet Yildirim; Yakup Ersel Aksoy; Mehmet Bulent Vatan; Hamad Dheir; Mustafa Altındis
Journal:  Singapore Med J       Date:  2018-10-10       Impact factor: 1.858

2.  Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer.

Authors:  Madhuri Jayathirtha; Anca-Narcisa Neagu; Danielle Whitham; Shelby Alwine; Costel C Darie
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

3.  The role of serum salusin alpha and beta levels and atherosclerotic risk factors in idiopathic sudden hearing loss pathogenesis.

Authors:  Sena Genç Elden; Mahmut Sinan Yılmaz; Mustafa Altındiş; Mehmet Köroğlu; Halil Elden
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-04-18       Impact factor: 2.503

Review 4.  Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases.

Authors:  Kengo Sato; Rena Watanabe; Fumiko Itoh; Masayoshi Shichiri; Takuya Watanabe
Journal:  Int J Hypertens       Date:  2013-10-22       Impact factor: 2.420

5.  Increased serum salusin-α by aerobic exercise training correlates with improvements in arterial stiffness in middle-aged and older adults.

Authors:  Shumpei Fujie; Natsuki Hasegawa; Kiyoshi Sanada; Takafumi Hamaoka; Seiji Maeda; Jaume Padilla; Luis A Martinez-Lemus; Motoyuki Iemitsu
Journal:  Aging (Albany NY)       Date:  2020-01-09       Impact factor: 5.682

6.  Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?

Authors:  Urszula Kołakowska; Elżbieta Kuroczycka-Saniutycz; Anna Wasilewska; Witold Olański
Journal:  Pediatr Nephrol       Date:  2014-09-23       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.